Back to Trades
Agah Ramtin
Chief Medical OfficerDirectorCIK 0001862617
Profile
- Filings
- 7
- Buy transactions
- 7
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 7 filings between 2025–2026, Agah Ramtin, Chief Medical Officer, Director, has disclosed $665.3K in transactions — all concentrated in RenovoRx, Inc. (RNXT). Their disclosed trades are heavily weighted toward buying — $56.0K in buys and $0 in sells. The largest single open-market purchase on record is $17.6K in RenovoRx, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Apr 7 | RNXT RenovoRx, Inc. | Agah Ramtin | Chief Medical Officer, Director | Award | $609.3K |
| Jan 22 | RNXT RenovoRx, Inc. | Agah Ramtin | Chief Medical Officer, Director | Buy | $10.0K |
| Jan 5 | RNXT RenovoRx, Inc. | Agah Ramtin | Chief Medical Officer, Director | Buy | $8.4K |
| Jan 2 | RNXT RenovoRx, Inc. | Agah Ramtin | Chief Medical Officer, Director | Buy | $169 |
| Dec 17 | RNXT RenovoRx, Inc. | Agah Ramtin | Chief Medical Officer, Director | Buy | $10.2K |
| Dec 8 | RNXT RenovoRx, Inc. | Agah Ramtin | Chief Medical Officer, Director | Buy | $9.6K |
| Nov 24 | RNXT RenovoRx, Inc. | Agah Ramtin | Chief Medical Officer, Director | Buy | $17.6K |
7 filings